超声评估颈动脉校正血流时间变化在未分化休克液体反应性中的价值
本研究为前瞻性非干预性研究,纳入ICU中新发未分化休克且液体复苏后仍需升压药的患者77例,排除显著心脏病及无法完成被动抬腿者。通过超声测量被动抬腿前后颈动脉校正血流时间变化,以无创心输出量监测(NICOM)评估被动抬腿后每搏输出量增加>10%定义为液体反应性。结果显示液体反应者54例(70.1%),其颈动脉校正血流时间平均变化为14.1±18.7 ms,无反应者为-4.0±8 ms(p<0.001)。ROC曲线下面积0.88(95%CI 0.80-0.96),被动抬腿后颈动脉校正血流时间升高7 ms预测液体反应性的阳性预测值为97%,准确率82%。机械通气、呼吸频率及高呼气末正压对检测性能无显著影响,盲法复核一致性良好。
要点
- 在未分化休克且仍需升压药的患者中,被动抬腿后颈动脉校正血流时间升高7 ms预测液体反应性的阳性预测值为97%,准确率82%。
- 液体反应者被动抬腿后颈动脉校正血流时间平均变化为14.1±18.7 ms,无反应者为-4.0±8 ms(p<0.001)。
- 颈动脉校正血流时间变化预测液体反应性的ROC曲线下面积为0.88(95%CI 0.80-0.96)。
- 机械通气、呼吸频率及高呼气末正压对颈动脉校正血流时间检测性能无显著影响。
- 盲法复核显示床旁获取的测量结果在评估者间具有一致性。
适用人群与场景
- 纳入:ICU中新发未分化休克且液体复苏后仍需升压药的患者。
- 排除:显著心脏病患者及无法完成被动抬腿操作的患者。
诊断标准与关键阈值
- 液体反应性定义:被动抬腿后无创心输出量监测(NICOM)显示每搏输出量增加>10%。
- 预测阈值:被动抬腿后颈动脉校正血流时间升高7 ms,阳性预测值97%,准确率82%。
处置流程与药物剂量
- 测量被动抬腿前后颈动脉校正血流时间,计算其变化值以预测液体反应性。
研究设计与关键结果
- 前瞻性非干预性研究,纳入77例未分化休克患者,其中54例(70.1%)为液体反应者。
- 液体反应者被动抬腿后颈动脉校正血流时间平均变化14.1±18.7 ms,无反应者为-4.0±8 ms(p<0.001)。
- ROC曲线下面积0.88(95%CI 0.80-0.96);被动抬腿后颈动脉校正血流时间升高7 ms的阳性预测值97%,准确率82%。
- 机械通气、呼吸频率及高呼气末正压对检测性能无显著影响;盲法复核评估者间一致性良好。
证据类型、等级与局限
- 证据类型:前瞻性非干预性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,床旁超声评估被动抬腿后颈动脉校正血流时间变化是一种可接受且可重复的无创方法,可用于识别未分化休克危重患者的液体反应性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Adequate assessment of fluid responsiveness in shock necessitates correct interpretation of hemodynamic changes induced by preload challenge. This study evaluates the accuracy of point-of-care Doppler ultrasound assessment of the change in carotid corrected flow time induced by a passive leg raise maneuver as a predictor of fluid responsiveness. Noninvasive cardiac output monitoring (NICOM, Cheetah Medical, Newton Center, MA) system based on a bioreactance method was used.
DESIGN: Prospective, noninterventional study.
SETTING: ICU at a large academic center.
PATIENTS: Patients with new, undifferentiated shock, and vasopressor requirements despite fluid resuscitation were included. Patients with significant cardiac disease and conditions that precluded adequate passive leg raising were excluded.
INTERVENTIONS: Carotid corrected flow time was measured via ultrasound before and after a passive leg raise maneuver. Predicted fluid responsiveness was defined as greater than 10% increase in stroke volume on noninvasive cardiac output monitoring following passive leg raise. Images and measurements were reanalyzed by a second, blinded physician. The accuracy of change in carotid corrected flow time to predict fluid responsiveness was evaluated using receiver operating characteristic analysis.
MEASUREMENTS AND MAIN RESULTS: Seventy-seven subjects were enrolled with 54 (70.1%) classified as fluid responders by noninvasive cardiac output monitoring. The average change in carotid corrected flow time after passive leg raise for fluid responders was 14.1 ± 18.7 ms versus -4.0 ± 8 ms for nonresponders (p < 0.001). Receiver operating characteristic analysis demonstrated that change in carotid corrected flow time is an accurate predictor of fluid responsiveness status (area under the curve, 0.88; 95% CI, 0.80-0.96) and a 7 ms increase in carotid corrected flow time post passive leg raise was shown to have a 97% positive predictive value and 82% accuracy in detecting fluid responsiveness using noninvasive cardiac output monitoring as a reference standard. Mechanical ventilation, respiratory rate, and high positive end-expiratory pressure had no significant impact on test performance. Post hoc blinded evaluation of bedside acquired measurements demonstrated agreement between evaluators.
CONCLUSIONS: Change in carotid corrected flow time can predict fluid responsiveness status after a passive leg raise maneuver. Using point-of-care ultrasound to assess change in carotid corrected flow time is an acceptable and reproducible method for noninvasive identification of fluid responsiveness in critically ill patients with undifferentiated shock.
参考来源
- Barjaktarevic I, Toppen WE, Hu S, et al. Ultrasound Assessment of the Change in Carotid Corrected Flow Time in Fluid Responsiveness in Undifferentiated Shock. Crit Care Med. 2018. PMID: 30134304. doi:10.1097/CCM.0000000000003356
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。